A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Latest Information Update: 17 Feb 2020
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Headache; Migraine
- Focus Registrational; Therapeutic Use
- Sponsors Allergan
- 09 Feb 2020 Primary endpoint (Days with headache) has not been met, as per Results published in the Headache
- 09 Feb 2020 Results published in the Headache
- 05 Oct 2016 Status changed from active, no longer recruiting to completed.